Search Results
World Health Organization Munich . [17]. ICH 1994 Q2A Validation of Analytical Procedure: Methodology International Conference on
. [2]. World Health Organization (WHO) : Draft stability testing of active pharmaceutical ingredients and pharmaceutical products , Geneva, 2007 . [3]. Committee for Proprietary Medicinal
. 21 2351 . [5]. World Health Organization , WHO Monographs on Selected Medicinal Plants , Geneva, 1999 , pp. 231 – 240 . [6
. 2 117 . [22]. Guidelines for Pre-Clinical Evaluation and Clinical Trials in Osteoporosis. World Health Organization , Geneva , 1998
. [18]. Quality Control Guidelines for Medicinal Plant Materials World Health Organization, Geneva , 1998 . Available at http
.G. Stephenson 1984 J. Agric. Food Chem. 32 566 . [10]. Food and Agriculture Organization of the United Nations , Food and
://www.fda.gov/ICECI/Inspections/InspectionGuides/ucm074922.htm (accessed 27/10/2009). [2]. World Health Organization , Supplementary guidelines on good manufacturing practices (GMP) : Validation, Working document QAS/03.055/Rev.2, pp 24–33, available at
]. European Agency for the Evaluation of Medicinal Products 2002 International Conference on Harmonisation. World Health Organization Guideline for Good Clinical Practice WHO
identified: concerns about the profitability of firms and uncertainties in tendering systems may hinder firms in adopting Industry 4.0 technologies. As is the case with any change, organisational resistance to adopting new technologies can be the most
1977 Self-Organization in Non-Equilibrium Systems Wiley New York . [21]. M. Sajewicz
